These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 37808914)

  • 1. Mucormycosis in 2023: an update on pathogenesis and management.
    Alqarihi A; Kontoyiannis DP; Ibrahim AS
    Front Cell Infect Microbiol; 2023; 13():1254919. PubMed ID: 37808914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis.
    Lynch JP; Fishbein MC; Abtin F; Zhanel GG
    Expert Rev Anti Infect Ther; 2023; 21(7):723-736. PubMed ID: 37262298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucormycosis: update on clinical presentation, diagnosis, and treatment.
    Dailey Garnes NJM; Kontoyiannis DP
    Curr Opin Infect Dis; 2023 Dec; 36(6):427-435. PubMed ID: 37732771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
    Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
    J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis.
    Alqarihi A; Gebremariam T; Gu Y; Swidergall M; Alkhazraji S; Soliman SSM; Bruno VM; Edwards JE; Filler SG; Uppuluri P; Ibrahim AS
    mBio; 2020 Jun; 11(3):. PubMed ID: 32487760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran.
    Abdorahimi M; Pakdel F; Salehi M; Alcazar-Fuoli L; Hashemi SJ; Daie Ghazvini R; Ahmadkhani F; Ahmadikia K; Abdollahi A; Debran JCS; Tabari A; Farrokh F; Mousavand A; Afarinesh Khaki P; Salami Khaneshan A; Ibrahim AS; Khodavaisy S
    Mycopathologia; 2023 Oct; 188(5):783-792. PubMed ID: 37672164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms that govern infection and antifungal resistance in Mucorales.
    Lax C; Nicolás FE; Navarro E; Garre V
    Microbiol Mol Biol Rev; 2024 Mar; 88(1):e0018822. PubMed ID: 38445820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary mucormycosis.
    Hamilos G; Samonis G; Kontoyiannis DP
    Semin Respir Crit Care Med; 2011 Dec; 32(6):693-702. PubMed ID: 22167397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finegoldia magna and Mucorales molds co-infection in a severe case of SARS-CoV-2 disease.
    Hristova R; Vlahova A; Christova M; Stamatov K; Stanimirov P
    J Infect Dev Ctries; 2023 Sep; 17(9):1231-1236. PubMed ID: 37824356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mucormycosis: Current and future management perspective].
    Martín Gómez MT; Salavert Lletí M
    Rev Iberoam Micol; 2021; 38(2):91-100. PubMed ID: 34144835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.
    Liu M; Spellberg B; Phan QT; Fu Y; Fu Y; Lee AS; Edwards JE; Filler SG; Ibrahim AS
    J Clin Invest; 2010 Jun; 120(6):1914-24. PubMed ID: 20484814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucormycosis in Africa: Epidemiology, diagnosis and treatment outcomes.
    Osaigbovo II; Ekeng BE; Davies AA; Oladele RO
    Mycoses; 2023 Jul; 66(7):555-562. PubMed ID: 36856432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactoferrin, a potential iron-chelator as an adjunct treatment for mucormycosis - A comprehensive review.
    Singh A; Ahmad N; Varadarajan A; Vikram N; Singh TP; Sharma S; Sharma P
    Int J Biol Macromol; 2021 Sep; 187():988-998. PubMed ID: 34324905
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Szebenyi C; Gu Y; Gebremariam T; Kocsubé S; Kiss-Vetráb S; Jáger O; Patai R; Spisák K; Sinka R; Binder U; Homa M; Vágvölgyi C; Ibrahim AS; Nagy G; Papp T
    mBio; 2023 Feb; 14(1):e0338622. PubMed ID: 36625576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-iron assimilation: pathogenesis and novel therapies of mucormycosis.
    Ibrahim AS
    Mycoses; 2014 Dec; 57 Suppl 3(0 3):13-7. PubMed ID: 25178879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries.
    Rudramurthy SM; Hoenigl M; Meis JF; Cornely OA; Muthu V; Gangneux JP; Perfect J; Chakrabarti A;
    Mycoses; 2021 Sep; 64(9):1028-1037. PubMed ID: 34133816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT; Muzny CA; Swiatlo E; Legendre DP
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review on Mucormycosis: Pathogenesis, Epidemiology, Microbiology and Diagnosis.
    Sharma A; Alam MA; Dhoundiyal S; Sharma PK
    Infect Disord Drug Targets; 2024; 24(1):e220823220209. PubMed ID: 37608614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.
    Pana ZD; Seidel D; Skiada A; Groll AH; Petrikkos G; Cornely OA; Roilides E;
    BMC Infect Dis; 2016 Nov; 16(1):667. PubMed ID: 27832748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.